Pradeep Tyagi Selected Research

Mental Disorders (Mental Disorder)

8/2018

Drug Targets in Neurotrophin Signaling in the Central and Peripheral Nervous System.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Pradeep Tyagi Research Topics

Disease

26	Inflammation (Inflammations) 11/2023 - 07/2006
23	Interstitial Cystitis (Interstitial Cystitis, Chronic) 01/2021 - 07/2006
21	Overactive Urinary Bladder (Overactive Bladder) 01/2023 - 10/2008
14	Spinal Cord Injuries (Spinal Cord Injury) 02/2024 - 10/2007
14	Cystitis 01/2022 - 05/2004
11	Pain (Aches) 01/2023 - 04/2007
8	Underactive Urinary Bladder 01/2022 - 01/2014
6	Urinary Bladder Neoplasms (Bladder Cancer) 05/2024 - 07/2006
6	Neoplasms (Cancer) 01/2023 - 11/2004
5	Ataxia (Dyssynergia) 01/2021 - 10/2007
4	Lower Urinary Tract Symptoms 01/2023 - 01/2010
4	Neurogenic Urinary Bladder (Bladder, Neurogenic) 03/2022 - 10/2007
4	Prostatitis 10/2019 - 04/2007
3	Hypersensitivity (Allergy) 09/2019 - 01/2016
3	Shock 09/2019 - 08/2016
3	Abnormal Reflex (Hyperreflexia) 04/2015 - 01/2004
3	Urinary Bladder Diseases (Bladder Diseases) 01/2014 - 05/2004
3	Urologic Diseases (Urinary Tract Disease) 04/2011 - 02/2010
2	Urinary Retention 01/2023 - 01/2018
2	Prostatic Hyperplasia (Benign Prostatic Hyperplasia) 01/2022 - 10/2019
2	Hyperplasia 01/2022 - 01/2015
2	Fibrosis (Cirrhosis) 11/2018 - 08/2017
2	Chronic Pain 08/2018 - 01/2016
2	Obesity 01/2018 - 07/2015
2	Hemorrhagic Cystitis 01/2014 - 04/2013
2	Prostatic Neoplasms (Prostate Cancer) 02/2010 - 11/2004
2	Wounds and Injuries (Trauma) 10/2007 - 06/2003
1	Drug-Related Side Effects and Adverse Reactions 01/2023
1	Body Weight (Weight, Body) 01/2023
1	Cicatrix (Scar) 03/2022
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2022

Drug/Important Bio-Agent (IBA)

18	Nerve Growth Factor (NGF)IBA 12/2021 - 07/2006
9	Biomarkers (Surrogate Marker)IBA 11/2023 - 02/2009
9	Liposomes (Liposome)IBA 12/2021 - 11/2004
8	CytokinesIBA 11/2023 - 02/2009
7	Capsaicin (Zostrix)FDA Link 02/2024 - 01/2004
7	Proteins (Proteins, Gene)FDA Link 11/2023 - 11/2004
7	Therapeutic UsesIBA 01/2023 - 01/2010
7	Cyclophosphamide (Cytoxan)FDA LinkGeneric 04/2015 - 05/2004
6	ChemokinesIBA 11/2023 - 09/2010
6	Type A Botulinum Toxins (Botox)FDA Link 01/2023 - 04/2007
6	Formaldehyde (Formol)FDA Link 01/2021 - 01/2014
6	Messenger RNA (mRNA)IBA 01/2021 - 03/2015
5	Interleukin-6 (Interleukin 6)IBA 11/2023 - 06/2012
5	Brain-Derived Neurotrophic Factor (BDNF)IBA 01/2021 - 01/2017
4	Muscarinic AntagonistsIBA 01/2023 - 09/2010
4	Antisense OligonucleotidesIBA 12/2021 - 08/2013
4	Botulinum Toxins (Botulinum Toxin)IBA 01/2017 - 01/2014
4	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2016 - 09/2010
4	Tacrolimus (Prograf)FDA LinkGeneric 08/2015 - 03/2011
3	gadobutrolIBA 01/2023 - 03/2018
3	Muscarinic Receptors (Muscarinic Acetylcholine Receptor)IBA 01/2023 - 04/2015
3	CollagenIBA 01/2022 - 08/2017
3	ProstaglandinsIBA 01/2018 - 12/2010
3	salicylhydroxamic acid (SHAM)IBA 01/2017 - 01/2015
3	Acetic Acid (Vinegar)FDA LinkGeneric 12/2016 - 01/2016
3	Dinoprostone (PGE2)FDA Link 01/2014 - 12/2010
3	mirabegronIBA 05/2013 - 10/2010
2	Interleukin-18 (Interleukin 18)IBA 11/2023 - 01/2015
2	PolymersIBA 01/2023 - 05/2004
2	SolutionsIBA 01/2023 - 01/2023
2	LM11A-31IBA 03/2022 - 11/2018
2	Nerve Growth Factors (Neurotrophins)IBA 03/2022 - 08/2018
2	Ferrosoferric Oxide (Magnetite)FDA Link 01/2020 - 03/2018
2	incobotulinumtoxinA FDA Link 10/2019 - 04/2007
2	Hematoxylin (Haematoxylon)IBA 01/2019 - 03/2015
2	Eosine Yellowish-(YS) (Eosin)IBA 01/2019 - 03/2015
2	Adrenergic Receptors (Adrenergic Receptor)IBA 08/2017 - 10/2010
2	Analgesics (Analgesic Drugs)IBA 08/2017 - 04/2007
2	OligonucleotidesIBA 01/2016 - 07/2006
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2016 - 09/2010
2	AndrogensIBA 03/2015 - 04/2014
2	CannabinoidsIBA 01/2010 - 04/2009
2	LigandsIBA 10/2005 - 11/2004
1	Immune Checkpoint InhibitorsIBA 05/2024
1	Interleukin-5 (Interleukin 5)IBA 11/2023
1	Fluorescein (Funduscein)FDA LinkGeneric 01/2023
1	oxybutynin (Tavor)FDA LinkGeneric 01/2023
1	Lidocaine (Xylocaine)FDA LinkGeneric 01/2023
1	IceIBA 01/2023
1	Mitomycin (Mitomycin-C)FDA LinkGeneric 01/2023
1	GadoliniumIBA 01/2023
1	BAY 58-2667IBA 03/2022
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 03/2022
1	Neuroprotective AgentsIBA 03/2022
1	IvabradineIBA 01/2022
1	Cytochromes c (Cytochrome c)IBA 01/2022
1	Soluble Guanylyl CyclaseIBA 01/2022
1	Heme (Haem)IBA 01/2022
1	Caspase 3 (Caspase-3)IBA 01/2022
1	Acid Sensing Ion ChannelsIBA 01/2021

Therapy/Procedure

24	Therapeutics 12/2021 - 01/2004
6	Extracorporeal Shockwave Therapy 01/2022 - 08/2017
4	Intravesical Administration 05/2024 - 01/2014
3	Drug Therapy (Chemotherapy) 01/2014 - 07/2006
2	Nerve Block (Nerve Blocks) 01/2023 - 01/2017
2	Cystectomy 11/2018 - 01/2014
2	Radiotherapy 11/2018 - 01/2014
2	Lasers (Laser) 01/2017 - 04/2015
1	Injections 05/2024